- Title
- Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre
- Creator
- Latimer, Julie; Ling, Stephen; Flaherty, Ian; Jauncey, Marianne; Salmon, Allison M.
- Relation
- International Journal of Drug Policy Vol. 37, Issue November 2016, p. 111-114
- Publisher Link
- http://dx.doi.org/10.1016/j.drugpo.2016.08.004
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2016
- Description
- Fentanyl, a rapid acting, short duration synthetic opioid, is a powerful analgesic approximately 100 times more potent than morphine (Chodoff & Domino, 1965). Listed on Australia’s Pharmaceutical Benefits Scheme in 2006 for the treatment of persistent non-cancer pain, fentanyl is available in several formulations including a transdermal patch, prescription of which has increased markedly in recent years both in Australia (Roxburgh et al., 2013) and North America (Compton & Volkow, 2006).
- Subject
- fentanyl; drug overdose; Pharmaceutical Benefits Scheme (PBS); Medically Supervised Injecting Centre; Sydney, N.S.W.
- Identifier
- http://hdl.handle.net/1959.13/1345004
- Identifier
- uon:29544
- Identifier
- ISSN:0955-3959
- Language
- eng
- Reviewed
- Hits: 7045
- Visitors: 5298
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|